Entering text into the input field will update the search result below

Biondvax Pharmaceuticals GAAP EPS of $0.00 beats by $0.73

May 15, 2023 5:56 PM ETScinai Immunotherapeutics Ltd. (SCNI) StockBy: Pranav Ghumatkar, SA News Editor
  • Biondvax Pharmaceuticals press release (NASDAQ:BVXV): Q1 GAAP EPS of $0.00 beats by $0.73.
  • As of March 31, 2023, BiondVax had cash and cash equivalents of $10.9 million as compared to $14.2 million as of December 31, 2022. The decrease in cash from December 31, 2022, to March 31, 2023, was primarily due to net cash used in operating activities of $3.1 million.

Recommended For You

More Trending News

About SCNI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SCNI--
Scinai Immunotherapeutics Ltd.